This bill amends current law to empower the therapeutic cannabis oversight board to regulate and review the labels and educational materials of cannabis products. It also prohibits the sale of hemp products containing THC levels greater than 0.03% on a dry weight basis, including delta-8 THC, delta-9 THC, or any other THC isomer variant. The bill does not have a fiscal impact on state, county, or local expenditures or revenues, according to the Department of Health and Human Services.

Statutes affected:
As Amended by the Senate: 126-X:12